Family Medicine Doctors in Quogue, NY Accepting Medicare
3 Family Medicine doctors found. Showing 1 - 3
 Ashley Ott, P.A. Family Medicine Medicare: Medicare Enrolled Practice Location: 33 Montauk Hwy, Quogue, NY 11959 Phone: 631-653-6000 |
 Dr. Paul James Endres, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 82 Jessup Avenue, Po Box 1215, Quogue, NY 11959 Phone: 212-729-7228 |
Dr. Lewis Seth Anreder, M.D. Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 33 Montauk Highway, Quogue, NY 11959 Phone: 631-653-6000 Fax: 631-653-8310 |
News Archive
Blood vessel plug - amplatzer ductal occluder, performs well in trial
In the largest and longest trial yet of a device called the Amplatzer ductal occluder, a duct that shunts blood flow away from the lungs during fetal development but sometimes fails to close after birth, was successfully closed in almost all patients, according to a new study in the Aug. 4, 2004, issue of the Journal of the American College of Cardiology.
Experimental drug outperforms standard first-line therapy for advanced kidney cancer patients
An experimental kidney cancer drug outperformed the standard first-line therapy for patients with metastatic disease who are considered at risk for poorer than average outcomes, according to results of a randomized phase II clinical trial by researchers at Dana-Farber Cancer Institute.
South Asian Health Foundation wins BMJ "Diabetes team of the year" award
The South Asian Health Foundation (SAHF) has been named ‘Diabetes Team of the Year' at the prestigious 2015 BMJ Awards...
Danaher acquires AB SCIEX and Molecular Devices
Danaher Corporation announced today that it has completed the previously announced acquisition of AB SCIEX and Molecular Devices.
FDA advisory committee recommends approval of Novartis' FTY720 for relapsing MS
Today, an advisory committee of the US Food and Drug Administration (FDA) recommended approval of FTY720 (fingolimod) for the treatment of patients with relapsing multiple sclerosis, the most common form of the disease. The FDA has the option of seeking the advice of one of its advisory committees as it reviews and decides whether to approve a new treatment. The committee voted unanimously that FTY720 demonstrated substantial efficacy in treating relapsing remitting MS and that safety of the proposed 0.5 mg dose justified approval.
› Verified 5 days ago